As a Stanford Biodesign Innovation Fellow, Kate Rosenbluth was captivated by the unmet need to treat hand tremors. She discovered that the site of deep brain stimulation was accessible through the peripheral nerves in the wrist, and teamed up with Scott Delp, director of the Stanford Neuromuscular Biomechanics Lab, to found Cala Health, where she is now the chief scientific officer. The company’s wearable neuromodulation therapies merge neuroscience research with cutting-edge technology to deliver individualized peripheral nerve stimulation. Here, she presents a framework for “needs-based innovation,” and explores how she emphasized a needs-based approach in the context of Cala Health.
Related
Josh Wolfe,
Lux Capital
Investing at the Cutting Edge [Entire Talk]
The entrepreneurs that attract venture capital investments think differently and tackle big problems that few others are willing to
Josh Wolfe,
Lux Capital
Investing at the Cutting Edge [Entire Talk]
The entrepreneurs that attract venture capital investments think differently and tackle big problems that few others are willing to
Rahul Roy-Chowdhury,
Grammarly
Responsible AI Innovation [Entire Talk]
AI tools are the future of technology. People have the power to ensure AI benefits us.
Rahul Roy-Chowdhury,
Grammarly
Responsible AI Innovation [Entire Talk]
AI tools are the future of technology. People have the power to ensure AI benefits us.
Claire Hughes Johnson,
Stripe
Scaling Operations and People [Entire Talk]
Build a company that is ready to scale with a strong foundation of values, well-built operating structures, and a complementary team.
Claire Hughes Johnson,
Stripe
Scaling Operations and People [Entire Talk]
Build a company that is ready to scale with a strong foundation of values, well-built operating structures, and a complementary team.
